Economic analysis of conventional-dose chemotherapy compared with high-dose chemotherapy plus autologous hematopoietic stem-cell transplantation for metastatic breast cancer

Metastatic Breast ◽

High Dose Chemotherapy ◽

High Dose ◽

Hematopoietic Stem ◽

Conventional Dose ◽

Conventional Dose Chemotherapy

Conventional-Dose Chemotherapy Compared with High-Dose Chemotherapy plus Autologous Hematopoietic Stem-Cell Transplantation for Metastatic Breast Cancer

New England Journal of Medicine ◽

10.1056/nejm200004133421501 ◽

2000 ◽

Vol 342 (15) ◽

pp. 1069-1076 ◽

Cited By ~ 297

Author(s):

Edward A. Stadtmauer ◽

Anne O'Neill ◽

Lori J. Goldstein ◽

Pamela A. Crilley ◽

Kenneth F. Mangan ◽

...

Keyword(s):

Breast Cancer ◽

Stem Cell ◽

Metastatic Breast ◽

High Dose Chemotherapy ◽

High Dose ◽

Hematopoietic Stem ◽

Conventional Dose ◽

Conventional Dose Chemotherapy

Factors Correlated With Progression-Free Survival After High-Dose Chemotherapy and Hematopoietic Stem Cell Transplantation for Metastatic Breast Cancer

JAMA ◽

10.1001/jama.282.14.1335 ◽

1999 ◽

Vol 282 (14) ◽

pp. 1335 ◽

Cited By ~ 52

Author(s):

Philip A. Rowlings

Keyword(s):

Breast Cancer ◽

Stem Cell ◽

Metastatic Breast ◽

Progression Free Survival ◽

High Dose Chemotherapy ◽

High Dose ◽

Hematopoietic Stem ◽

Free Survival

High dose chemotherapy (HDCT) and hematopoietic stem cell transplantation (HPSCT) with subsequent immunotherapy in metastatic breast cancer (MBC): Final results of a phase I stud

10.1200/jco.2004.22.14_suppl.726 ◽

2004 ◽

Vol 22 (14_suppl) ◽

pp. 726-726

Author(s):

H. J. Stemmler ◽

C. Salat ◽

H. Lindhofer ◽

M. Menzel ◽

H. Sauer ◽

...

Keyword(s):

Breast Cancer ◽

Stem Cell ◽

Phase I ◽

Metastatic Breast ◽

High Dose Chemotherapy ◽

High Dose ◽

Highly favorable outcome in BRCA-mutated metastatic breast cancer patients receiving high-dose chemotherapy and autologous hematopoietic stem cell transplantation

Bone Marrow Transplantation ◽

10.1038/bmt.2016.82 ◽

2016 ◽

Vol 51 (8) ◽

pp. 1082-1086 ◽

Cited By ~ 9

Author(s):

L Boudin ◽

A Gonçalves ◽

R Sabatier ◽

J Moretta ◽

P Sfumato ◽

...

Keyword(s):

Breast Cancer ◽

Stem Cell ◽

Metastatic Breast ◽

High Dose Chemotherapy ◽

High Dose ◽

Breast Cancer Patients ◽

High dose chemotherapy (HDCT) and hematopoietic stem cell transplantation (HPSCT) with subsequent immunotherapy in metastatic breast cancer (MBC): Final results of a phase I stud

10.1200/jco.2004.22.90140.726 ◽

2004 ◽

Vol 22 (14_suppl) ◽

pp. 726-726

Author(s):

H. J. Stemmler ◽

C. Salat ◽

H. Lindhofer ◽

M. Menzel ◽

H. Sauer ◽

...

Keyword(s):

Breast Cancer ◽

Stem Cell ◽

Phase I ◽

Metastatic Breast ◽

High Dose Chemotherapy ◽

High Dose ◽

Interleukin-2 (IL-2) with high-dose chemotherapy (HDC) and autologous hematopoietic stem-cell transplantation (AHST) for poor-risk metastatic breast cancer (MBC)

10.1200/jco.2004.22.90140.6664 ◽

2004 ◽

Vol 22 (14_suppl) ◽

pp. 6664-6664

Author(s):

Y. C. C. Cheng ◽

G. Rondón ◽

D. R. Couriel ◽

M. J. De Lima ◽

C. Hosing ◽

...

Keyword(s):

Breast Cancer ◽

Stem Cell ◽

Interleukin 2 ◽

Metastatic Breast ◽

High Dose Chemotherapy ◽

High Dose ◽

Prognostic Value of EMT-Circulating Tumor Cells in Metastatic Breast Cancer Patients Undergoing High-Dose Chemotherapy with Autologous Hematopoietic Stem Cell Transplantation

Journal of Cancer ◽

10.7150/jca.5111 ◽

2012 ◽

Vol 3 ◽

pp. 369-380 ◽

Cited By ~ 45

Author(s):

Michal Mego ◽

Hui Gao ◽

Bang-Ning Lee ◽

Evan N. Cohen ◽

Sanda Tin ◽

...

Keyword(s):

Breast Cancer ◽

Stem Cell ◽

Prognostic Value ◽

Metastatic Breast ◽

High Dose Chemotherapy ◽

High Dose ◽

Breast Cancer Patients ◽

Paclitaxel and Trastuzumab as Maintenance Therapy in Patients with HER2-Positive Metastatic Breast Cancer Who Underwent High-Dose Chemotherapy and Autologous Hematopoietic Stem Cell Transplantation

Journal of Cancer ◽

10.7150/jca.6775 ◽

2013 ◽

Vol 4 (8) ◽

pp. 679-685 ◽

Cited By ~ 3

Author(s):

Yee Chung Cheng ◽

Gabriela Rondón ◽

Paolo Anderlini ◽

Issa F. Khouri ◽

Richard E. Champlin ◽

...

Keyword(s):

Breast Cancer ◽

Stem Cell ◽

Maintenance Therapy ◽

Metastatic Breast ◽

High Dose Chemotherapy ◽

High Dose ◽

Her2 Positive ◽

Predicting outcome based on swenerton score in patients with metastatic breast cancer undergoing high-dose chemotherapy and autologous hematopoietic stem cell transplantation: implications for patient selection

Biology of Blood and Marrow Transplantation ◽

10.1016/s1083-8791(03)00088-0 ◽

2003 ◽

Vol 9 (5) ◽

pp. 330-340 ◽

Cited By ~ 5

Author(s):

Filippo Montemurro ◽

Gabriela Rondón ◽

Mark Munsell ◽

Terry L Smith ◽

Michele L Donato ◽

...

Keyword(s):

Breast Cancer ◽

Stem Cell ◽

Metastatic Breast ◽

High Dose Chemotherapy ◽

High Dose ◽

Hematopoietic Stem ◽

Predicting Outcome

Interleukin-2 (IL-2) with high-dose chemotherapy (HDC) and autologous hematopoietic stem-cell transplantation (AHST) for poor-risk metastatic breast cancer (MBC)

10.1200/jco.2004.22.14_suppl.6664 ◽

2004 ◽

Vol 22 (14_suppl) ◽

pp. 6664-6664

Author(s):

Y. C. C. Cheng ◽

G. Rondón ◽

D. R. Couriel ◽

M. J. De Lima ◽

C. Hosing ◽

...

Keyword(s):

Breast Cancer ◽

Stem Cell ◽

Interleukin 2 ◽

Metastatic Breast ◽

High Dose Chemotherapy ◽

High Dose ◽